News | July 23, 2025
Lonza reports 19% growth in sales in H1
Upgrades 2025 full-year CDMO sales and margin outlook
Upgrades 2025 full-year CDMO sales and margin outlook
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Extended lab space for product development, customer demos, and training
Star Health Insurance is modernising its claims ecosystem to be future-ready
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Subscribe To Our Newsletter & Stay Updated
